Clinical Trials

New Search
Title   A Phase 1b/2, Open-Label, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of SM88 in Patients With Prostate Cancer
Disease/Condition   Prostate Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Neoplasms,Urogenital Neoplasms
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Benjamin Gartrell, MD
Contact Name   Gina Aracena
Contact Email   gihernan@montefiore.org
IRB/Protocol Number   18-06-199-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Medical and Hematologic Oncology - Prostate